ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

#133_2022_May_Injectables_SHL_Hero5

PUTTING PROCESS ENGINEERING INTO ACTION

SHL Medical's Jonathan Kearns and Kevin Huang consider how engineering competencies are being driven to the next level by leveraging process engineering and how this can transform drug-device projects.

IMPROVING CLINICAL OUTCOMES WITH A PATIENT-CENTRIC AND REUSABLE PEN PLATFORM

Cécile Gross and Radosław Romańczuk discuss Nemera’s Pendura AD pen platform and present case studies demonstrating how it can be tailored to address the user’s needs and meet pharma industry constraints.

GLASS-FILLED CELANEX^® MT^® PBT HITS SWEET SPOT FOR BIOLOGICS AND REUSABLE DEVICES

Bryan Deacon, Marnik Vaes and Peter Burke, introduce a medical-grade glass-filled engineering polymer, Celanex^® MT^® PBT 2406MT GF20, which fills a gap in the materials market between standard engineering thermoplastics and expensive high-performance polymers.

PREMIUMCOAT<sup>®</sup> SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS

PREFILLED SYRINGES

Sebastien Cordier

PREMIUMCOAT^® SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS

Sébastien Cordier, Vincent Holterboch and Estelle Verger discuss how coated elastomer components, such as Aptar Pharma’s PremiumCoat^®, can help drug developers optimise the balance between component processability and minimising silicone migration into a drug product.

INJECTING THE FUTURE

INJECTING THE FUTURE

Simone Farina discusses Flex’s new smart autoinjector platform for the healthcare market, designed to enable original equipment manufacturers to accelerate time-to-market, reduce costs and boost reliability, while ensuring patient compliance.

CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN

Jabil Healthcare

CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN

Oliver Eden discusses the factors that drive the design and development of a reusable autoinjector solution. Foremost amongst these considerations is the patient, in terms of ease of use with the device itself and maximising access to the broadest possible population with a versatile, portfolio-enabling platform ready for the connected world.

ADVANCEMENTS AND EVOLUTION OF POWER SOURCES IN DRUG DELIVERY

ADVANCEMENTS AND EVOLUTION OF POWER SOURCES IN DRUG DELIVERY

William Welch considers the evolution of compressed gas alternatives to spring power for single-use drug delivery devices.

A CHECKLIST FOR AUTOINJECTOR DESIGN

A CHECKLIST FOR AUTOINJECTOR DESIGN

Michael Earl outlines the five key questions autoinjector designers typically ask during the development process and the choices available for tailoring autoinjector products.

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Dr Fred Metzmann

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Fred Metzmann and Chris Muenzer discuss the simplicity of the PiccoJect™ autoinjector platform and the company's commitment to sustainability.

Technology Showcase: CCBio’s Felice Dose

Technology Showcase: CCBio’s Felice Dose

CCBio introduces its wearable (on-body) injector, Felice Dose, which is capable of handling various drug volumes, concentrations and viscosities, as well as different injection speeds and delivery times.

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

PREFILLED SYRINGES

Hiroki Hasegawa

Mitsubishi Gas Chemical

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

Hiroki Hasegawa and Tomohiro Suzuki provide an overview of the OXYCAPT multilayer vial and syringe, along with a discussion of how OXYCAPT fares at low and very low temperatures.

XERIJECT™: NON-AQUEOUS FORMULATIONS FOR SC INJECTION OF ULTRA-HIGH-CONCENTRATION BIOLOGICS

Dr Steven Prestrelski

Xeris Pharmaceuticals

XERIJECT™: NON-AQUEOUS FORMULATIONS FOR SC INJECTION OF ULTRA-HIGH-CONCENTRATION BIOLOGICS

Steven Prestrelski introduces the XeriJect non-aqueous formulation technology that creates formulations with visco-elastic properties, opening the door to subcutaneous injection of difficult-to-formulate biologics, such as monoclonal antibodies, at very high concentrations.

EXTRACELLULAR VESICLE ENGINEERING: OPTIMISING NATURE’S NON-IMMUNOGENIC, DRUG DELIVERY PLATFORM

Dr Anna Cifuentes-Rius

EXTRACELLULAR VESICLE ENGINEERING: OPTIMISING NATURE’S NON-IMMUNOGENIC, DRUG DELIVERY PLATFORM

Anna Cifuentes-Rius discusses the exciting potential of extracellular vesicles to advance drug delivery, in particular their natural ability to carry API payloads across difficult-to-traverse biological barriers.

ENABLING A NEW PARADIGM FOR PEPTIDE DRUG DEVELOPMENT

Xeris Pharmaceuticals

ENABLING A NEW PARADIGM FOR PEPTIDE DRUG DEVELOPMENT

Michael Neely reviews peptide formulations and introduces Xeris's XeriSol™ technology and its potential paradigm-changing capabilities.

RECENT TRENDS & DEVELOPMENTS IN INJECTABLE FORMULATION & DELIVERY

Dr Martin Gonzalez

RECENT TRENDS & DEVELOPMENTS IN INJECTABLE FORMULATION & DELIVERY

Martin Gonzalez details current trends in sterile injectable formulations and their delivery devices, and the challenges pharma and its contract development and manufacturing company partners face in bringing emerging breakthroughs to market.

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

Stevanato Group

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

In this exclusive interview, Steven Kaufman of Stevanato Group, and Michael Earl of Owen Mumford, talked with us about their companies' recent major agreement for the manufacturing and provision of prefillable syringes for the advanced two-step, single-use autoinjector, Aidaptus^®.

INTERVIEW: AURELIO ARIAS, IQVIA

INTERVIEW: AURELIO ARIAS, IQVIA

Aurelio Arias of IQVIA discusses trends in the drug delivery industry, including how device and packaging manufacturers are increasingly aligning as strategic partners to speed innovation and reduce reliance on pharma investment.

ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?

ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?

Rob Udale, Catriona Eldridge and Omar Shah assess the assertion that pMDIs are the most environmentally damaging of the available pulmonary drug delivery device archetypes, and explore some of the intricacies not accounted for in the public discourse surrounding pMDIs.

SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?

Cambridge Design Partnership

SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?

Fran Penrose considers the lessons the healthcare sector can draw from the fast-moving consumer sector when designing for sustainability and asks, “Can we go even further?”

SUSTAINABILITY IN MEDTECH DEVELOPMENT: AN ITERATIVE APPROACH BASED ON ECODESIGN AND LIFE CYCLE SCREENINGS

Christoffer Thomsen

SUSTAINABILITY IN MEDTECH DEVELOPMENT: AN ITERATIVE APPROACH BASED ON ECODESIGN AND LIFE CYCLE SCREENINGS

Life Cycle Assessments are a valuable but time-consuming and, ultimately, retrospective method for assessing MedTech product sustainability. Christoffer Thomsen and Peter Werner Hansen dive into an iterative and data-driven approach to more sustainable MedTech development based on Ecodesign and Life Cycle Screenings.

SMART SOLUTIONS TO REDUCE CARBON FOOTPRINT

SMART SOLUTIONS TO REDUCE CARBON FOOTPRINT

Rob Doorakkers and Geert van Amstel discuss why the company decided to become carbon neutral, how it is working to make injection moulding more sustainable and how the organisation is minimising its impact on the environment.

DESIGNING DRUG DELIVERY DEVICES TO MEET EMERGING NEEDS AND SUSTAINABILITY GOALS

Dr Pierre Moulinie

DESIGNING DRUG DELIVERY DEVICES TO MEET EMERGING NEEDS AND SUSTAINABILITY GOALS

Pierre Moulinié, Isaac Platte and Lauren Zetts discuss how polycarbonate-based materials deliver value to emerging drug delivery devices.

HOW CAN THE PHARMA INDUSTRY PREPARE FOR NEW pMDI PROPELLANTS?

HOW CAN THE PHARMA INDUSTRY PREPARE FOR NEW pMDI PROPELLANTS?

Nick Atkinson looks at the changes that are set to hit pressurised metered dose inhaler manufacturing as new propellants are introduced and how pharma companies can prepare for the switch.

CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY

Dr Jnanadeva Bhat

CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY

Jnanadeva Bhat and Anita Solanki discuss the role that hard capsules are able to play in delivering a more sustainable pharmaceutical industry, both as an oral solid dosage form and in dry powder inhalers.

SUSTAINABILITY CONSIDERATIONS FOR END-TO-END DRUG DELIVERY DEVICE SOLUTIONS

SUSTAINABILITY CONSIDERATIONS FOR END-TO-END DRUG DELIVERY DEVICE SOLUTIONS

Barbara Lead outlines the sustainability efforts undertaken by SMC Group associated companies, including facilitating the transition from hospital to at-home treatment and investment in greener facilities.

INVESTIGATING THE PROPELLANT PATHWAYS LEADING TO A SUSTAINABLE FUTURE FOR MDIS

INVESTIGATING THE PROPELLANT PATHWAYS LEADING TO A SUSTAINABLE FUTURE FOR MDIS

Chris Baron and Jag Shur discuss the various dynamics involved in realising the full potential of MDIs to deliver both improved environmental performance and even better patient outcomes.

Conference Showcase: Pharmapack Europe 2022 – Education, Innovation, Networking

CONFERENCE SHOWCASE

Conference Showcase: Pharmapack Europe 2022 – Education, Innovation, Networking

Pharmapack 2022 takes place in-person at Paris Expo on May 18–19, 2022. The two day in-person event will host more than 50 sessions (online and in-person), networking with 300+ exhibitors covering the pharma packaging and drug delivery industry,and live conference sessions covering three tracks. As a smart event, digital on-demand sessions and other resources are available for a week before and after the physical show.

NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY

Frédérique Bordes-Picard

NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY

Frédérique Bordes-Picard looks at the role of nanotechnology in the nasal and pulmonary routes of drug delivery and explains how nanoparticle explains how nanoparticle solutions could transform patient comfort and compliance.

WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022

WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022

Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.

PERSONALISED AEROSOL LOADING AND MANAGEMENT (PALM): A HAND-HELD DEVICE FOR AEROSOL DRUG DELIVERY

Dr Jason Brenker

Monash University

PERSONALISED AEROSOL LOADING AND MANAGEMENT (PALM): A HAND-HELD DEVICE FOR AEROSOL DRUG DELIVERY

Jason Brenker, Tuncay Alan and Daniela Traini introduce the PALM – Personalised Aerosol Loading and Management – device, a unique, advanced drug delivery device enabling personalised delivery of aerosols to improve the efficacy of inhaled medications and patient compliance.

DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?

Wilbur de Kruijf

DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?

Wilbur de Kruijf and Bernhard Müllinger discuss the the market requirements for new inhalation options and the benefits of soft mist inhalers.

NOSE-TO-BRAIN DRUG ADMINISTRATION AND A NOVEL APPROACH WITH AN OLD FAMILIAR

Dr Marie-Christine Klein

NOSE-TO-BRAIN DRUG ADMINISTRATION AND A NOVEL APPROACH WITH AN OLD FAMILIAR

Marie-Christine Klein, Andreas Bilstein and Rouven Kraus look at the advantages of the nose-to-brain route and soft mist nasal sprays for drug administration.

Technology Showcase: Testing Solutions for pMDI Drug Development

Proveris Scientific

Technology Showcase: Testing Solutions for pMDI Drug Development

Proveris Scientific showcases its complete suite of testing solutions for pMDI drug development, which include Proveris by Design, Ergo Studies, Vereo SFMDx Actuators, and a new Kinaero Cx pMDI Collection System.

USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY

Dr Justin Lacombe

USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY

Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.

INTERVIEW: JON LENN & JON VOLMER, MEDPHARM

INTERVIEW: JON LENN & JON VOLMER, MEDPHARM

Jon Lenn and Jon Volmer talked with Guy Furness about the importance of nasal modelling, focusing on MedPharm’s own nasal cavity modelling technology, MedCast, its unique characteristics and benefits and the value it brings to the company’s offering for nasally delivered products.

AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS

Dr Caterina Minelli

AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS

Caterina Minelli discusses the importance of co-operation between metrology institutes and the pharmaceutical industry in the pursuit of improving analytical techniques and standards for the characterisation of particle attributes in drug development.

NASAL DELIVERY SYSTEM EXPANDS PUBLIC AND PATIENT ACCESS TO NALOXONE TO MITIGATE THE OPIOID OVERDOSE EPIDEMIC

NASAL DELIVERY SYSTEM EXPANDS PUBLIC AND PATIENT ACCESS TO NALOXONE TO MITIGATE THE OPIOID OVERDOSE EPIDEMIC

Todd D Pizitz and Donald R Mealing discuss the ongoing US opioid epidemic, the CounterAct cap containing a single dose of naloxone to be attached to prescribed opioids, and a recent pilot market study done to gauge public enthusiasm for this life-saving technology.

EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS

EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS

Daniel Lock discusses the latest innovations in nebuliser technology for drug delivery to the lungs.

MANUFACTURING DPIs: AN ENGINEERING PERSPECTIVE

MANUFACTURING DPIs: AN ENGINEERING PERSPECTIVE

Pietro Pirera discusses the optimal process parameters for microdose dry power inhalers achieved by dosator technology.

1
2
3
…
30
Next

See what ondrugdelivery's readers and contributors think

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Top